These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15672589)

  • 1. [Against meningococcus: a new form of vaccination].
    Triau R; Merieux C
    Bull Acad Natl Med; 1979 Mar; 163(3):277-88. PubMed ID: 15672589
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward a meningitis-free world.
    Black S; Pizza M; Nissum M; Rappuoli R
    Sci Transl Med; 2012 Feb; 4(123):123ps5. PubMed ID: 22378923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines against bacterial meningitis.
    Segal S; Pollard AJ
    Br Med Bull; 2004; 72():65-81. PubMed ID: 15802609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccine prevention of bacterial meningitis].
    Gaudelus J; Letamendia-Richard E; Burlot K; de Pontual L
    Arch Pediatr; 2003 May; 10 Suppl 1():118s-121s. PubMed ID: 14509767
    [No Abstract]   [Full Text] [Related]  

  • 5. A new approach to the definition of seroconversion following vaccination in a population with high background antibody concentrations.
    Chandramohan D; Coleman P; Nelson C; Greenwood B
    Vaccine; 2007 Sep; 25 Suppl 1():A58-62. PubMed ID: 17524529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statement on meningococcal vaccination for travellers. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine (CATMAT)
    Can Commun Dis Rep; 2009 Jun; 35(ACS-4):1-22. PubMed ID: 19526652
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 May; 33(ACS-3):1-23. PubMed ID: 17520774
    [No Abstract]   [Full Text] [Related]  

  • 8. New meningococcal vaccine recommendations under consideration.
    Turner JC
    J Am Coll Health; 2004; 53(2):89-91. PubMed ID: 15495886
    [No Abstract]   [Full Text] [Related]  

  • 9. Meningococcal meningitis.
    Aguado T; Bertherat E; Djingarey M; Kandolo D; Kieny MP; Kondé K; LaForce FM; Nelson CB; Perea W; Préziosi MP
    Nat Rev Microbiol; 2005 Jan; 3(1):10-1. PubMed ID: 15635779
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recommendation of vaccination against meningitis C in Cantabria].
    González de Aledo Linos A
    An Esp Pediatr; 2001 Oct; 55(4):379-80. PubMed ID: 11578550
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
    Heyderman RS; Davenport V; Williams NA
    Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal vaccination for college freshmen.
    Bröker M
    Cleve Clin J Med; 2001 Oct; 68(10):879. PubMed ID: 11596625
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing the risk of meningitis among incoming freshmen.
    FDA Consum; 2001; 35(5):4-5. PubMed ID: 11697094
    [No Abstract]   [Full Text] [Related]  

  • 14. [Meningococcal vaccination. Early prevention against dangerous pathogens].
    MMW Fortschr Med; 2009 Jan; 151(1-2):20. PubMed ID: 19227636
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
    Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
    Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt.
    Nakhla I; Frenck RW; Teleb NA; El Oun S; Sultan Y; Mansour H; Mahoney F
    Vaccine; 2005 May; 23(25):3288-93. PubMed ID: 15837234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
    Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
    Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conquering the meningococcus.
    Stephens DS
    FEMS Microbiol Rev; 2007 Jan; 31(1):3-14. PubMed ID: 17233633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Meningitis Vaccine Project.
    LaForce FM; Konde K; Viviani S; Préziosi MP
    Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.